DSM Venturing

DSM Venturing is the corporate venture capital arm of Royal DSM, established in 2001 and headquartered in Heerlen, Netherlands. The firm focuses on investing in start-up companies that develop innovative products and services within the life sciences sector, which encompasses both animal and human health and nutrition. Over the years, DSM Venturing has invested in more than fifty emerging companies across the United States, Europe, and Israel. Its primary objective is to generate strategic options and enhance value for DSM and its broader ecosystem while achieving sustainable venture-grade investment returns.

Rob Beudeker

Investment Director

Scott Horner

Regional Managing Director North America

Marcel Kloosterman

Investment Manager

Greg McParland

Investment Director

Erik Rutten

Senior Investment Manager

88 past transactions

Vivici

Series A in 2025
Vivici is a B2B ingredients firm that provides nutritious and sustainable animal-free dairy proteins manufactured with precision fermentation to food and beverage manufacturers.

NutriLeads

Series C in 2023
NutriLeads is a startup focused on developing innovative nutritional ingredients with clinically proven health benefits. The company specializes in precision prebiotic fibers derived from crops, which are designed to support physiological processes and modulate the gut microbiome. NutriLeads collaborates with industry partners to identify promising lead ingredients, create sustainable and commercially viable production processes, and initiate scientific and clinical programs that validate the health effects of its offerings. By doing so, NutriLeads aims to enhance nutritional health innovation in the food industry, ultimately providing consumers and patients with access to dietary supplements and specialized functional food and beverage products that deliver these benefits.

Octarine Bio

Series A in 2023
Octarine Bio is a biotechnology company based in Copenhagen, Denmark, founded in 2018. The company specializes in the research and development of cannabinoid and psilocybin derivatives using synthetic biology. By employing a biosynthetic platform, Octarine Bio aims to create a range of natural and novel cannabinoid and psilocybin-derived molecules that possess enhanced pharmacokinetic and therapeutic properties. These advancements are designed to support healthcare professionals in treating neurological and psychological disorders, ultimately improving the health and well-being of individuals.

Vivici

Seed Round in 2023
Vivici is a B2B ingredients firm that provides nutritious and sustainable animal-free dairy proteins manufactured with precision fermentation to food and beverage manufacturers.

Meatable

Series B in 2023
Meatable is a food production company specializing in the creation of cultured meat through advanced stem cell technology. By utilizing pluripotent stem cells, which can differentiate into various cell types such as muscle and fat without the need for serum, Meatable's innovative approach allows for the production of meat without extracting tissue from animals. This method not only promotes sustainability but also offers consumers a guilt-free alternative to traditional meat. The company's focus on efficient and responsible food production positions it as a leader in the emerging market for lab-grown meat.

Incredo

Series C in 2023
Incredo, a global food-tech company founded in 2014, specializes in developing innovative technologies to enhance the sweetness of sugars without leaving an aftertaste. Based in Petach-Tikva, Israel, the company focuses on creating solutions that significantly reduce sugar consumption while maintaining the sensory qualities consumers expect from sweet foods. Incredo's proprietary technology allows for a sugar reduction made from real cane sugar, ensuring that taste, mouthfeel, and texture are preserved. By enabling healthier consumption of foods and snacks, Incredo provides consumers with the opportunity to enjoy their favorite products with substantial sugar reduction, ultimately promoting better dietary choices.

VitaminLab

Series A in 2023
VitaminLab is a biopharmaceutical company focused on providing personalized vitamins tailored to individual health needs. Utilizing a matching algorithm, the company combines health history, nutrient testing, and health data to create customized supplements. Founded by a team of pharmacists and healthcare professionals, VitaminLab aims to transform the supplement industry by offering products made from all-natural ingredients, including beetroot, stevia, and prebiotics. By considering factors such as DNA, blood composition, and body type, VitaminLab delivers a unique approach to supplement formulation that prioritizes individual health and wellness.

Athian

Seed Round in 2023
Athian is a technology company based in Indianapolis, Indiana, that focuses on promoting environmental sustainability within the livestock sector. By utilizing a cloud-based platform, Athian aggregates, certifies, and funds greenhouse gas reduction plans across the beef and dairy value chains. The company aims to help livestock producers capture and monetize carbon credits generated through their sustainability initiatives. Athian's platform serves as an analytics tool that delivers validated greenhouse gas credits to various stakeholders, including food retailers and service providers, thereby enabling them to support sustainable practices in animal agriculture. The company is backed by notable industry leaders such as Elanco Animal Health and Tyson Ventures, highlighting its commitment to enhancing the economic and environmental health of farms and the surrounding communities.

Paleo

Series A in 2023
Paleo is a food ingredient company focused on developing innovative, animal-free heme proteins for plant-based meat and fish alternatives. Utilizing precision fermentation, Paleo produces bio-identical heme proteins that are non-GMO and replicate the sensory and nutritional qualities of their animal-derived counterparts. This technology allows businesses to create sustainable food products that not only taste and feel like real meat or fish but also align with ethical considerations by avoiding harm to animals. Through its commitment to bioscience, Paleo aims to enhance the flavor and appeal of plant-based foods, contributing to a healthier and more sustainable food system.

Meala Foodtech

Pre Seed Round in 2023
Meala is a food technology company focused on developing functional proteins aimed at transforming the plant-based protein sector. The company utilizes naturally occurring biocatalysts to enhance plant-based proteins, creating meat-like textures and juiciness that closely resemble animal-derived products. This innovative approach allows producers to formulate cleaner labels and healthier options with fewer ingredients, catering to the growing demand for plant-based alternatives in the food industry. Through its advancements, Meala seeks to provide effective solutions for meat replacements, positioning itself as a key player in the evolution of sustainable protein sources.

Miach Orthopaedics

Series B in 2023
Miach Orthopaedics is a medical device company based in Westborough, Massachusetts, founded in 2016. The company specializes in developing bio-engineered surgical implants aimed at facilitating new tissue growth and aiding in connective tissue repair. Its primary product, the Bridge-Enhanced ACL Repair technology, offers a viable alternative to traditional anterior cruciate ligament (ACL) reconstruction for patients who have suffered ACL injuries. This innovative approach enables surgeons to restore the normal anatomy and function of the knee, enhancing recovery outcomes for patients.

Flore by Sun Genomics

Series B in 2022
Sun Genomics, Inc. is a microbiome health company based in San Diego, California, specializing in customized probiotics aimed at addressing dysbiosis. Founded in 2014, the company’s flagship product, Floré, combines a gut microbiome test with personalized probiotic formulations tailored to individual gut profiles, assessed through whole-genome sequencing. The Floré Gut Test includes a microflora collection kit, a comprehensive microflora profile analysis, and wellness consultations. Additionally, Sun Genomics offers Floré Tots, a probiotic solution designed for children up to age 12, which comes in a convenient powder form that can be easily mixed with beverages. The company sells its products online, providing an automatic renewal service to enhance customer convenience.

Octarine Bio

Seed Round in 2022
Octarine Bio is a biotechnology company based in Copenhagen, Denmark, founded in 2018. The company specializes in the research and development of cannabinoid and psilocybin derivatives using synthetic biology. By employing a biosynthetic platform, Octarine Bio aims to create a range of natural and novel cannabinoid and psilocybin-derived molecules that possess enhanced pharmacokinetic and therapeutic properties. These advancements are designed to support healthcare professionals in treating neurological and psychological disorders, ultimately improving the health and well-being of individuals.

Momentous

Series A in 2022
Momentous is a nutritional supplement company based in Palo Alto, California, founded in 2016 by Matt Wan and Rob Dyrdek. The company specializes in performance products tailored for athletes, utilizing insights from experts in professional sports leagues such as the NFL, NBA, and NHL. Momentous emphasizes the use of high-quality, organic, and gluten-free ingredients in its formulations, ensuring that its supplements are clean, safe, and effective. The product line is designed to enhance athletic performance while providing exceptional taste without the use of fillers.

Rootine

Series A in 2022
Rootine is a precision health company focused on optimizing individual health through the integration of personal health data and tailored nutrition solutions. By utilizing technology, Rootine analyzes clients' biological needs and provides personalized vitamin regimens based on real-time data. The company offers precision lab tests and wearable analytics to help users understand what their bodies require for peak performance. Through a dedicated dashboard, individuals can track their progress, with artificial intelligence refining recommendations and nutrient formulas as their health evolves. Rootine aims to empower users, whether they are seasoned athletes or new to health management, to enhance their energy, productivity, and overall well-being.

Phytolon

Series A in 2022
Phytolon Ltd, founded in 2000 and based in Misgav, Israel, specializes in the development of natural food colorants. The company has established a novel and sustainable technology that utilizes fermentation processes with baker’s yeast cells as biofactories to produce high-quality, plant-based food colors. This innovative approach provides a healthy alternative to synthetic food dyes, offering food manufacturers safe, cost-effective, and stable all-natural colors. Phytolon is dedicated to promoting human health and environmental sustainability through scientific advancement in the food color industry.

Chinova Bioworks

Series A in 2022
Chinova Bioworks Inc. specializes in developing natural antimicrobials for the beverage industry, focusing on enhancing the shelf life of fresh juices. Founded in 2016 and based in Fredericton, Canada, the company utilizes a chitosan polymer derived from fungal-sourced technology, specifically natural fibers from mushrooms. This broad-spectrum preservative effectively protects products from spoilage while remaining a healthy, natural ingredient suitable for use in foods, beverages, cosmetics, and personal care items. By providing manufacturers with a solution to improve product quality and freshness, Chinova Bioworks aims to increase consumer satisfaction and reduce food waste.

Inne

Series A in 2022
Inne is a Berlin-based biotech startup focused on developing a hormone-based mini lab designed for women to monitor their fertility. The company aims to provide a convenient and accurate method for natural contraception, enabling women to better understand their bodies and make informed choices regarding their reproductive health. Inne's innovative device analyzes fertility hormones in saliva, offering insights into ovulation, menstrual cycles, and hormone levels. By utilizing biochemistry combined with a user-friendly app, Inne empowers women to identify their fertility phases based on hormonal readings, fostering a greater awareness of their overall female health.

OK Capsule

Seed Round in 2022
OK Capsule is a B2B platform that provides the technology, products, fulfillment, and strategic support that makes it safe, simple, and sustainable for companies to launch and scale the delivery of personalized nutrition to their customers.

ATRO Medical

Venture Round in 2021
ATRO Medical B.V., based in Nijmegen, the Netherlands, focuses on developing innovative solutions for knee joint health through its anatomically shaped meniscus implant, the Trammpolin. This implant is designed to restore the protective function of the meniscus by acting as a joint spacer, thus alleviating pain and improving life quality for patients suffering from osteoarthritis. The company emerged as a spin-out from DSM and Radboudumc, leveraging insights gained from a collaborative initiative that began in 2010, involving various universities and private enterprises with support from the Dutch government. The Trammpolin prosthesis is a synthetic, non-resorbable substitute that mimics the natural meniscus, functioning effectively as a shock absorber by ensuring adequate load distribution within the knee joint.

OK Capsule

Seed Round in 2021
OK Capsule is a B2B platform that provides the technology, products, fulfillment, and strategic support that makes it safe, simple, and sustainable for companies to launch and scale the delivery of personalized nutrition to their customers.

Rootine

Seed Round in 2021
Rootine is a precision health company focused on optimizing individual health through the integration of personal health data and tailored nutrition solutions. By utilizing technology, Rootine analyzes clients' biological needs and provides personalized vitamin regimens based on real-time data. The company offers precision lab tests and wearable analytics to help users understand what their bodies require for peak performance. Through a dedicated dashboard, individuals can track their progress, with artificial intelligence refining recommendations and nutrient formulas as their health evolves. Rootine aims to empower users, whether they are seasoned athletes or new to health management, to enhance their energy, productivity, and overall well-being.

Prenexus Health

Series B in 2021
Prenexus Health, Inc. is a company that specializes in the research, development, and production of natural prebiotic ingredients designed for functional foods, beverages, and dietary supplements. Founded in 2015 and based in Gilbert, Arizona, Prenexus Health focuses on digestive health and wellness through its innovative prebiotic offerings, such as XOS95, a highly purified ingredient derived from high-fiber sugarcane. The company's commitment to scientific and clinical research positions it as a leader in the prebiotic market, providing clients in the fast-moving consumer goods sector with effective ingredients that enhance the health benefits of their products.

Inkbit

Series B in 2021
Inkbit Corporation, founded in 2017 and based in Medford, Massachusetts, specializes in the research, development, and manufacturing of 3D printers. The company has developed an advanced additive manufacturing platform that integrates 3D printing with machine vision technology, allowing for the rapid production of polymer parts. By employing machine learning and artificial intelligence, Inkbit delivers a multi-material jetting platform that meets the speed and precision required for demanding industrial applications. The expertise of its team, comprised of MIT-trained scientists and engineers, spans industrial systems, design software, and material science, enabling Inkbit to bridge the gap between prototyping and large-scale manufacturing. This innovation facilitates the on-demand production of both multi-material and end-use products, positioning Inkbit as a leader in the mass-market additive manufacturing sector.

Leading Edge Equipment Technologies

Convertible Note in 2021
Leading Edge Equipment Technologies, Inc. is a manufacturer and supplier of equipment for solar panel production. Founded in 2008 and based in Wilmington, Massachusetts, the company specializes in developing kerfless, single-crystal silicon wafers designed to enhance the efficiency and reduce the costs of solar cells and panels. Their innovative floating silicon method eliminates the need for wire-sawing large silicon ingots, utilizing less energy-intensive furnaces and resulting in higher efficiency solar cells. This technology not only lowers manufacturing costs but also reduces emissions, making it an environmentally friendly option for solar panel manufacturers. Formerly known as Leading Edge Crystal Technologies, the company rebranded in May 2020 to reflect its focus on advanced equipment technologies in the renewable energy sector.

Brains Bioceutical

Series A in 2021
Brains Bioceutical Corp. is a Vancouver-based company that specializes in the production of naturally-sourced active pharmaceutical ingredients (APIs) for the pharmaceutical and nutraceutical industries. The company offers a range of products, including CBD oil, capsules, balms, and sprays, which are designed to serve various sectors such as health and wellness, skin and beauty, and veterinary care. Brains Bioceutical follows Good Manufacturing Practices (GMP) and emphasizes the use of high-quality, plant-based ingredients that are tetrahydrocannabinol-free, non-genetically modified, and vegan. This commitment allows the company to provide accessible and affordable products that meet the needs of patients seeking reliable wellness solutions.

Meatable

Series A in 2021
Meatable is a food production company specializing in the creation of cultured meat through advanced stem cell technology. By utilizing pluripotent stem cells, which can differentiate into various cell types such as muscle and fat without the need for serum, Meatable's innovative approach allows for the production of meat without extracting tissue from animals. This method not only promotes sustainability but also offers consumers a guilt-free alternative to traditional meat. The company's focus on efficient and responsible food production positions it as a leader in the emerging market for lab-grown meat.

Deep Branch Biotechnology

Series A in 2021
Deep Branch Biotechnology Ltd., founded in 2018 and based in Nottingham, UK, specializes in carbon recycling services aimed at creating sustainable ingredients for food and feed. By utilizing clean and renewable carbon and energy sources, the company employs a proprietary gas fermentation platform that leverages sustainable feedstocks to produce bio-based products with a significantly reduced carbon footprint. Deep Branch focuses on customer-driven research and development, enabling it to swiftly deliver innovative solutions to meet the growing demand for sustainable food systems. The company collaborates with local suppliers of strategic raw materials, fostering local economies while ensuring a reliable input supply. With a clear roadmap for scaling its operations, Deep Branch has formed strong partnerships across the value chain and has integrated effectively with carbon dioxide suppliers to optimize the deployment of its technology. By producing ingredients that require no arable land and minimal water, Deep Branch is addressing climate change and biodiversity loss, contributing to a more sustainable future without compromising on nutritional quality.

Novum Medical

Venture Round in 2021
Novum Medical specializes in the development of innovative orthopedic implants that utilize advanced biomaterials to enhance the interface between implants and bone. This approach aims to promote a more natural healing process and improve overall performance. The company focuses on resorbable ortho-biomaterials, which are made entirely from bioactive glass that possesses porous, load-bearing, and osteoconductive properties. These characteristics enable surgeons to reconstruct bony structures effectively while minimizing the clinical compromises associated with existing technologies. The applications of Novum Medical's products are broad, targeting various needs within the musculoskeletal system.

Additive Manufacturing Technologies

Series A in 2021
Additive Manufacturing Technologies (AMT) specializes in automated post-processing technology aimed at enhancing the efficiency of additive manufacturing operations. The company's flagship platform, PostPro, significantly improves the cost, quality, safety, and throughput involved in the production of 3D printed parts. By automating the traditionally manual and expensive post-production steps, AMT enables manufacturers to transition their facilities into high-volume production lines. This innovative approach not only accelerates lead times but also reduces overall manufacturing costs, making it an attractive solution for clients looking to scale their additive manufacturing capabilities.

Frontier Nutrition

Series B in 2021
Frontier Nutrition, Inc. is a company that develops and manufactures fortified packaged food products aimed at addressing the nutritional needs of low and middle-income families in underserved communities worldwide. Founded in 2017 by Eddie Bearnot and Tanveer Ali, the company is headquartered in New Haven, Connecticut. Frontier Nutrition's offerings are informed by research in pediatric nutrition and behavioral marketing, ensuring that recipes are tailored to local diets while being optimized for taste, nutrition, and affordability. The company's mission is to combat early life and maternal malnutrition by providing low-cost, convenient food options to families facing challenges such as limited access to healthcare, transportation, and clean water, thereby promoting a sustainable standard of living.

Leading Edge Equipment Technologies

Series A in 2020
Leading Edge Equipment Technologies, Inc. is a manufacturer and supplier of equipment for solar panel production. Founded in 2008 and based in Wilmington, Massachusetts, the company specializes in developing kerfless, single-crystal silicon wafers designed to enhance the efficiency and reduce the costs of solar cells and panels. Their innovative floating silicon method eliminates the need for wire-sawing large silicon ingots, utilizing less energy-intensive furnaces and resulting in higher efficiency solar cells. This technology not only lowers manufacturing costs but also reduces emissions, making it an environmentally friendly option for solar panel manufacturers. Formerly known as Leading Edge Crystal Technologies, the company rebranded in May 2020 to reflect its focus on advanced equipment technologies in the renewable energy sector.

NutriLeads

Series B in 2020
NutriLeads is a startup focused on developing innovative nutritional ingredients with clinically proven health benefits. The company specializes in precision prebiotic fibers derived from crops, which are designed to support physiological processes and modulate the gut microbiome. NutriLeads collaborates with industry partners to identify promising lead ingredients, create sustainable and commercially viable production processes, and initiate scientific and clinical programs that validate the health effects of its offerings. By doing so, NutriLeads aims to enhance nutritional health innovation in the food industry, ultimately providing consumers and patients with access to dietary supplements and specialized functional food and beverage products that deliver these benefits.

Phynova

Venture Round in 2020
Phynova Group Limited is a British life science company focused on developing and commercializing natural healthcare products derived from active compounds in plants, particularly those used in traditional Chinese medicine. Founded in 2002 and headquartered in Long Hanborough, UK, Phynova operates a research subsidiary in Beijing, China. The company’s portfolio includes drug candidates targeting various health issues such as gastroenterology, anti-infective conditions, metabolic disorders, and obesity. Notable drug candidates include Melokinex for postoperative ileus, PYN17 for chronic hepatitis C, and PYN22 for obesity and non-alcoholic fatty liver diseases. Additionally, Phynova develops functional ingredients and over-the-counter products like PhynoRadiance for cosmetic applications, FatigFix for fatigue reduction, and IminoNorm for prediabetes management. By harnessing the therapeutic potential of plants with historical medicinal use, Phynova aims to address contemporary global health challenges.

Panaceutics Nutrition

Series A in 2020
Panaceutics Inc. specializes in the formulation, manufacturing, and distribution of personalized nutritional products, focusing on mass customization based on individual genetic and medical profiles. Established in 2013 and headquartered in Research Triangle Park, North Carolina, the company employs proprietary robotic technology to create easy-to-swallow fruit purees that combine multiple pills into a single packet. This innovative approach caters to healthcare systems, pharmaceutical companies, and nutritional product manufacturers, enabling them to offer tailored supplementation that meets specific macro nutrient needs. By using automated methods, Panaceutics ensures that consumers receive convenient and safe nutritional solutions embedded in flavored gels and other food bases.

Inkbit

Venture Round in 2019
Inkbit Corporation, founded in 2017 and based in Medford, Massachusetts, specializes in the research, development, and manufacturing of 3D printers. The company has developed an advanced additive manufacturing platform that integrates 3D printing with machine vision technology, allowing for the rapid production of polymer parts. By employing machine learning and artificial intelligence, Inkbit delivers a multi-material jetting platform that meets the speed and precision required for demanding industrial applications. The expertise of its team, comprised of MIT-trained scientists and engineers, spans industrial systems, design software, and material science, enabling Inkbit to bridge the gap between prototyping and large-scale manufacturing. This innovation facilitates the on-demand production of both multi-material and end-use products, positioning Inkbit as a leader in the mass-market additive manufacturing sector.

Voxel8

Series B in 2019
Voxel8 Inc. is a technology company based in Somerville, Massachusetts, that specializes in the design and manufacture of electronic devices and advanced 3D printing solutions. Established in 2013, Voxel8 has developed a unique digital 3D printing technology that allows for the zonal tuning of mechanical properties in various textiles, making it applicable in sectors such as footwear, apparel, and medical devices. Their systems enable the customization of each print, enhancing both performance and aesthetics while minimizing waste through an additive manufacturing process. Additionally, Voxel8 offers Project Wire, a cloud-based software tool that facilitates the design of 3D printable electronic devices compatible with their printers. With a focus on sustainability, the company has created a range of bio-based materials aimed at reducing the carbon footprint associated with textile production. This innovative approach not only improves functional performance—such as abrasion resistance and cushioning—but also allows for the integration of 3D embellishments and color, significantly transforming the landscape of footwear and athletic apparel manufacturing.

Additive Manufacturing Technologies

Series A in 2019
Additive Manufacturing Technologies (AMT) specializes in automated post-processing technology aimed at enhancing the efficiency of additive manufacturing operations. The company's flagship platform, PostPro, significantly improves the cost, quality, safety, and throughput involved in the production of 3D printed parts. By automating the traditionally manual and expensive post-production steps, AMT enables manufacturers to transition their facilities into high-volume production lines. This innovative approach not only accelerates lead times but also reduces overall manufacturing costs, making it an attractive solution for clients looking to scale their additive manufacturing capabilities.

Chinova Bioworks

Seed Round in 2019
Chinova Bioworks Inc. specializes in developing natural antimicrobials for the beverage industry, focusing on enhancing the shelf life of fresh juices. Founded in 2016 and based in Fredericton, Canada, the company utilizes a chitosan polymer derived from fungal-sourced technology, specifically natural fibers from mushrooms. This broad-spectrum preservative effectively protects products from spoilage while remaining a healthy, natural ingredient suitable for use in foods, beverages, cosmetics, and personal care items. By providing manufacturers with a solution to improve product quality and freshness, Chinova Bioworks aims to increase consumer satisfaction and reduce food waste.

ZeaVision

Venture Round in 2019
ZeaVision develops products for EyeCare Professionals and patients. ZeaVision's mission is to develop and market science-based supplements and vision care products to support healthy vision and prevent vision loss in the lives of many.

Panaceutics Nutrition

Venture Round in 2019
Panaceutics Inc. specializes in the formulation, manufacturing, and distribution of personalized nutritional products, focusing on mass customization based on individual genetic and medical profiles. Established in 2013 and headquartered in Research Triangle Park, North Carolina, the company employs proprietary robotic technology to create easy-to-swallow fruit purees that combine multiple pills into a single packet. This innovative approach caters to healthcare systems, pharmaceutical companies, and nutritional product manufacturers, enabling them to offer tailored supplementation that meets specific macro nutrient needs. By using automated methods, Panaceutics ensures that consumers receive convenient and safe nutritional solutions embedded in flavored gels and other food bases.

Hyalex Orthopaedics

Series A in 2019
Hyalex Orthopaedics, Inc. is a medical device company based in Lexington, Massachusetts, focused on developing innovative products that utilize HYALEX technology, a synthetic polymer engineered to mimic cartilage. Founded in 2016, the company specializes in creating a biomimetic material that can effectively simulate healthy cartilage to treat diseased or damaged joints. The unique properties of HYALEX allow it to maintain low friction and wear, even under the significant loads typically experienced in human joints. This capability enables surgeons to replace arthritic cartilage while preserving healthy bone. Although Hyalex Orthopaedics is advancing its product development, its offerings have not yet received approval for use in humans from any regulatory agency.

Adaptive3D

Series A in 2019
Adaptive3D is a supplier of premium additive manufacturing polymer resins, focused on enabling high-volume production through optimized materials. The company collaborates with global leaders to provide solutions for functional end-use products and prototypes. Its product offerings include rubber-like 3D printable materials, damping materials, and low-cure stress photopolymers, all developed using innovative technologies. By delivering high-quality polymer resins and specialty polymers, Adaptive3D empowers clients to achieve differentiated products and enhanced part performance, featuring precise internal geometries and economically tailored components.

Raycatch

Series B in 2018
Raycatch Ltd. is an Israeli company that specializes in AI diagnostics technology for the solar energy sector. The company has developed an automated software-as-a-service platform that transforms the management of solar assets by analyzing existing data to facilitate on-demand maintenance and operational efficiency. Its application, DeepSolar™, provides daily analysis of production data, delivering comprehensive diagnostic insights for photovoltaic (PV) portfolios. These insights cover various aspects such as component performance, maintenance needs, and operational efficiencies, allowing solar plant owners to enhance energy yield and reduce operational costs without the need for hardware installation or site visits. By automating the decision-making process for solar asset management, Raycatch aims to improve profitability and promote the broader adoption of solar energy in the global market.

Miach Orthopaedics

Series A in 2018
Miach Orthopaedics is a medical device company based in Westborough, Massachusetts, founded in 2016. The company specializes in developing bio-engineered surgical implants aimed at facilitating new tissue growth and aiding in connective tissue repair. Its primary product, the Bridge-Enhanced ACL Repair technology, offers a viable alternative to traditional anterior cruciate ligament (ACL) reconstruction for patients who have suffered ACL injuries. This innovative approach enables surgeons to restore the normal anatomy and function of the knee, enhancing recovery outcomes for patients.

Novum Medical

Series C in 2018
Novum Medical specializes in the development of innovative orthopedic implants that utilize advanced biomaterials to enhance the interface between implants and bone. This approach aims to promote a more natural healing process and improve overall performance. The company focuses on resorbable ortho-biomaterials, which are made entirely from bioactive glass that possesses porous, load-bearing, and osteoconductive properties. These characteristics enable surgeons to reconstruct bony structures effectively while minimizing the clinical compromises associated with existing technologies. The applications of Novum Medical's products are broad, targeting various needs within the musculoskeletal system.

Chinova Bioworks

Seed Round in 2018
Chinova Bioworks Inc. specializes in developing natural antimicrobials for the beverage industry, focusing on enhancing the shelf life of fresh juices. Founded in 2016 and based in Fredericton, Canada, the company utilizes a chitosan polymer derived from fungal-sourced technology, specifically natural fibers from mushrooms. This broad-spectrum preservative effectively protects products from spoilage while remaining a healthy, natural ingredient suitable for use in foods, beverages, cosmetics, and personal care items. By providing manufacturers with a solution to improve product quality and freshness, Chinova Bioworks aims to increase consumer satisfaction and reduce food waste.

Chromatic 3D Materials

Series A in 2018
Chromatic 3D Materials specializes in the development of advanced 3D printing materials, focusing on durable elastomers suitable for manufacturing finished products. The company offers a platform that utilizes reactive extrusion additive manufacturing, allowing for the production of industrial-strength rubber parts. Their proprietary polyurethanes exhibit properties such as flexibility, resilience, and sustainability, catering to the needs of various industries that require adaptable and robust materials. By enabling innovative product designs through customizable material properties, Chromatic 3D Materials positions itself as a leader in the next generation of additive manufacturing solutions.

Tespo

Series A in 2018
Tespo manufactures a liquid vitamin dispenser helping individuals with health goals. The company's system provides all the storage, convenience, and daily use benefits of a vitamin pill without the drawbacks - no fillers, binders, additives, or unnecessary ingredients.

Leading Edge Equipment Technologies

Seed Round in 2017
Leading Edge Equipment Technologies, Inc. is a manufacturer and supplier of equipment for solar panel production. Founded in 2008 and based in Wilmington, Massachusetts, the company specializes in developing kerfless, single-crystal silicon wafers designed to enhance the efficiency and reduce the costs of solar cells and panels. Their innovative floating silicon method eliminates the need for wire-sawing large silicon ingots, utilizing less energy-intensive furnaces and resulting in higher efficiency solar cells. This technology not only lowers manufacturing costs but also reduces emissions, making it an environmentally friendly option for solar panel manufacturers. Formerly known as Leading Edge Crystal Technologies, the company rebranded in May 2020 to reflect its focus on advanced equipment technologies in the renewable energy sector.

ATRO Medical

Series A in 2017
ATRO Medical B.V., based in Nijmegen, the Netherlands, focuses on developing innovative solutions for knee joint health through its anatomically shaped meniscus implant, the Trammpolin. This implant is designed to restore the protective function of the meniscus by acting as a joint spacer, thus alleviating pain and improving life quality for patients suffering from osteoarthritis. The company emerged as a spin-out from DSM and Radboudumc, leveraging insights gained from a collaborative initiative that began in 2010, involving various universities and private enterprises with support from the Dutch government. The Trammpolin prosthesis is a synthetic, non-resorbable substitute that mimics the natural meniscus, functioning effectively as a shock absorber by ensuring adequate load distribution within the knee joint.

NutriLeads

Series A in 2017
NutriLeads is a startup focused on developing innovative nutritional ingredients with clinically proven health benefits. The company specializes in precision prebiotic fibers derived from crops, which are designed to support physiological processes and modulate the gut microbiome. NutriLeads collaborates with industry partners to identify promising lead ingredients, create sustainable and commercially viable production processes, and initiate scientific and clinical programs that validate the health effects of its offerings. By doing so, NutriLeads aims to enhance nutritional health innovation in the food industry, ultimately providing consumers and patients with access to dietary supplements and specialized functional food and beverage products that deliver these benefits.

QD Solar

Series A in 2017
QD Solar Inc. is a Canadian company based in Toronto that specializes in the development of advanced photovoltaic cells utilizing colloidal quantum dot technology. Founded in 2014 as a spinoff from the University of Toronto, QD Solar combines silicon solar cells with infrared solar cells in a hybrid architecture. This innovative approach allows the company to capture a broader range of the solar spectrum compared to traditional silicon cells alone. By enhancing the efficiency of solar energy harvesting, QD Solar aims to address the competitive pressures in the solar photovoltaic market, where differentiation through improved performance at competitive costs is essential. The company's technology promotes sustainable development and aims to increase the adoption of renewable energy sources.

WattGlass

Series A in 2017
WattGlass LLC, founded in 2014 and based in Fayetteville, Arkansas, specializes in developing innovative water-based anti-reflective coatings designed to eliminate reflection, glare, and fogging on glass and other transparent materials. The company's proprietary nanoparticle technology, initially developed during research at the University of Arkansas, offers a safe and environmentally friendly alternative to hazardous materials typically used in coatings. WattGlass's solutions cater to various industries, including automotive, consumer goods, architectural glass, and solar photovoltaic applications. The company has secured exclusive licensing for its technology and has filed multiple patents to further enhance its product offerings.

Essential Medical

Series B in 2016
Essential Medical, Inc. is a medical device company based in Malvern, Pennsylvania, that specializes in developing femoral artery vascular closure devices. Founded in 2010, the company focuses on sealing femoral punctures that occur after diagnostic and interventional cardiac catheterization procedures. Essential Medical has created two primary closure devices, including MANTA, which is specifically designed to address large bore punctures ranging from 10 to 24 French. These devices are particularly relevant for procedures such as transcatheter aortic valve replacement (TAVR), abdominal aortic aneurysm repair (AAA/PVAR), and balloon aortic valvuloplasty (BAV). The innovations from Essential Medical aim to fulfill a significant need in interventional cardiology by providing efficient closure solutions that minimize complications for patients. Since October 2018, the company operates as a subsidiary of Teleflex Incorporated.

Blue Prairie

Series A in 2016
Blue Prairie Brands LLC, based in Charlottesville, Virginia, specializes in the manufacture of inulin, a prebiotic ingredient known for its health benefits. The company produces soluble, indigestible fibers that enhance the nutritional content of various food products, beverages, and dietary supplements. Their flagship product is a gluten-free, non-GMO form of inulin, which supports digestive health when combined with probiotics. Additionally, Blue Prairie's innovative approach to production offers farmers a profitable rotation crop that aligns with their existing agricultural practices. By focusing on functional foods and dietary fiber, Blue Prairie Brands aims to improve the nutritional value of products in the market while promoting a healthy gut environment.

Arecor

Venture Round in 2016
Arecor Limited is a biopharmaceutical company based in Cambridge, United Kingdom, specializing in stabilization technology solutions for the pharmaceutical and biotech sectors. Founded in 2006, Arecor utilizes its innovative formulation technology platform to enhance the commercial value and utility of proteins across various applications, including vaccines and therapeutic proteins. The company develops products targeting infectious diseases, diabetes, oncology, immunology, and hormone replacement therapies. It focuses on reformulating existing therapies to improve their stability and efficacy, enabling self-administration for patients through pre-filled syringes and injection pens. Notably, Arecor works on high-concentration formulations of antibodies, such as Trastuzumab and Rituximab, to improve treatment for conditions like breast cancer and non-Hodgkin’s lymphoma. Additionally, Arecor creates stable liquid formulations for vaccines and biological therapies, addressing challenges in degradation and stability. Through partnerships with leading pharmaceutical companies, Arecor aims to deliver advanced reformulations that enhance treatment options for patients.

NOMADD Desert Solar Solutions

Series A in 2016
NOMADD specializes in innovative cleaning solutions for solar panels, particularly in desert environments. The company has developed the NOMADD, a no-water mechanical automated dusting device designed to address the unique challenges of maintaining solar panels in arid regions. This system effectively removes dust from solar panel surfaces without damaging the panels or using water, making it an environmentally friendly option. Headquartered in Saudi Arabia, NOMADD was developed at the King Abdullah University for Science and Technology, near Jeddah, and aims to support solar energy efficiency in regions with high levels of dust and soiling.

NutriLeads

Seed Round in 2015
NutriLeads is a startup focused on developing innovative nutritional ingredients with clinically proven health benefits. The company specializes in precision prebiotic fibers derived from crops, which are designed to support physiological processes and modulate the gut microbiome. NutriLeads collaborates with industry partners to identify promising lead ingredients, create sustainable and commercially viable production processes, and initiate scientific and clinical programs that validate the health effects of its offerings. By doing so, NutriLeads aims to enhance nutritional health innovation in the food industry, ultimately providing consumers and patients with access to dietary supplements and specialized functional food and beverage products that deliver these benefits.

Natreon

Venture Round in 2015
Natreon, Inc. specializes in the development and marketing of Ayurvedic products, focusing on dietary supplements derived from traditional herbal ingredients. The company's product lineup includes CAPROS, an all-natural antioxidant for cardiovascular health; SENSORIL, an Ashwagandha extract that promotes stress relief and cognitive function; AYUFLEX, aimed at supporting joint health; and PRIMAVIE, a mitochondrial energy booster. Natreon emphasizes extensive research and development, ensuring high standards of product quality through multiple clinical and safety studies. The company holds patents for its offerings both in the United States and internationally. Headquartered in New Brunswick, New Jersey, Natreon operates a state-of-the-art research facility in Kolkata, India, to enhance its innovative capabilities in Ayurvedic medicine.

NovoPolymers

Venture Round in 2015
NovoPolymers NV is a company focused on developing and producing sustainable solutions for the photovoltaic market. It specializes in creating front and back encapsulants designed to protect solar cells, which enhance the power output of both crystalline silicon and thin-film solar modules. By optimizing these encapsulants, NovoPolymers aims to add value throughout the photovoltaic supply chain, contributing to the efficiency and sustainability of solar energy production.

Interface Biologics

Series B in 2015
Interface Biologics, Inc. is a commercial stage company based in Toronto, Canada, that specializes in developing innovative biomedical polymer technologies aimed at enhancing the safety and effectiveness of medical devices. The company’s patent-protected technologies include anti-thrombogenic additives designed for blood-contacting medical devices and polymer-enabled combination drug delivery systems. Interface Biologics has established exclusive licensing agreements for its Endexo™ technology with AngioDynamics for vascular access catheters and with Fresenius Medical Care for chronic dialysis systems. Medical devices incorporating this technology, such as AngioDynamics’ BioFlo PICCS and DuraMax Dialysis Catheter, have received FDA clearance and are gaining market traction. Additionally, the company has a joint venture with Qualimed to develop a drug-coated balloon utilizing its Kinesyx™ technology. Founded in 2001, Interface Biologics operates from the MaRS Innovation Centre and focuses on solutions that reduce infection and thrombus-related complications across various medical specialties, particularly ophthalmology.

EyePromise

Venture Round in 2014
EyePromise is a manufacturer of dietary supplements focused on promoting ocular health and combating age-related vision loss. The company specializes in zeaxanthin supplements, which are designed for individuals at risk of developing age-related macular degeneration. EyePromise offers a range of products, including the EyePromise restore supplement, targeted for professional use, and EyePromise ten, which caters to consumers seeking zeaxanthin. Additionally, EyePromise provides the QuantifEYE program, a tool for assessing the risk of vision deterioration. Through its offerings, EyePromise aims to enhance visual performance, alleviate dry eyes, and support overall vision health.

Verdezyne

Venture Round in 2014
Verdezyne is a private company focused on synthetic biology, utilizing its expertise and advanced computational algorithms to design and synthesize diverse gene libraries for engineering proteins, metabolic pathways, and microorganisms. By optimizing commercial fermentation processes, Verdezyne produces renewable chemical alternatives to petrochemicals. The company’s innovative platform combines synthetic biology with established manufacturing technologies to create a wide range of building blocks, offering sustainable and cost-effective solutions for everyday chemicals and additives. This approach aims to reduce reliance on oil and transform traditional chemical production methods.

Isobionics

Venture Round in 2014
Isobionics is a company specializing in the production of natural aroma ingredients through a proprietary biotechnology process. It focuses on isoprenoid-based products for the food, beverage, flavor, and fragrance markets. The company develops high-quality and pure flavor and fragrance components, such as citrus oil derivatives like nootkatone and valencene. Using fermentation processes that are free from pesticides and seasonal variability, Isobionics serves various industries, including food, beverage, oral care, and personal care. This innovative approach allows Isobionics to offer customers a consistent sensory experience while maintaining lower production costs.

ChromaDex

Post in 2013
ChromaDex Corporation is a global nutraceutical company based in Los Angeles, California, focused on promoting healthy aging through innovative ingredient technologies. The company is best known for its flagship product, Nicotinamide riboside (NIAGEN), a patented form of vitamin B3 that enhances nicotinamide adenine dinucleotide (NAD+) levels, which naturally decline with age. In addition to NIAGEN, ChromaDex offers Immulina, a spirulina extract designed to improve immune function. The company operates through three main segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services, with the majority of its revenue generated from the Consumer Products segment. ChromaDex markets its products directly in the United States and Canada, while also utilizing international distributors, and employs in-house expertise in chemistry, regulatory affairs, and safety consulting to develop commercially viable ingredients across various industries, including dietary supplements, food, beverage, skin care, and pharmaceuticals.

Arecor

Venture Round in 2013
Arecor Limited is a biopharmaceutical company based in Cambridge, United Kingdom, specializing in stabilization technology solutions for the pharmaceutical and biotech sectors. Founded in 2006, Arecor utilizes its innovative formulation technology platform to enhance the commercial value and utility of proteins across various applications, including vaccines and therapeutic proteins. The company develops products targeting infectious diseases, diabetes, oncology, immunology, and hormone replacement therapies. It focuses on reformulating existing therapies to improve their stability and efficacy, enabling self-administration for patients through pre-filled syringes and injection pens. Notably, Arecor works on high-concentration formulations of antibodies, such as Trastuzumab and Rituximab, to improve treatment for conditions like breast cancer and non-Hodgkin’s lymphoma. Additionally, Arecor creates stable liquid formulations for vaccines and biological therapies, addressing challenges in degradation and stability. Through partnerships with leading pharmaceutical companies, Arecor aims to deliver advanced reformulations that enhance treatment options for patients.

Segetis

Series C in 2012
Segetis, Inc. is a green chemistry company specializing in the development, production, and commercialization of renewable polymers. Founded in 2006 and based in Golden Valley, Minnesota, the company utilizes a platform of binary monomers derived from renewable feedstocks, such as non-food agricultural and forestry materials. Segetis's innovative technology supports the production of a range of industrial bioproducts, including bio-plastics, surfactants, plasticizers, adhesives, and coalescent solvents, among others. The company's chemistries create opportunities for synergy across various industries, including those involved in starch and sugar crop processing, wood and cellulose processing, vegetable oil chemical processing, biodiesel manufacturing, and the production of linear alpha-olefins.

Xolve

Funding Round in 2012
Xolve, Inc. is a nanomaterials company based in Middleton, Wisconsin, specializing in the production and supply of graphene to enhance the properties of various industrial plastics. Founded in 2008, Xolve offers a range of products including graphene-loaded polymer master batches, pristine graphene nanoplatelets, and exfoliated graphene, which are utilized in sectors such as automotive, aerospace, and electronics. The company focuses on commercializing intellectual property that facilitates effective room temperature processing of graphene and nanoparticle composites, solutions, and coatings. Xolve's innovations aim to improve performance characteristics such as electrical and thermal conductivity and barrier properties while reducing production costs. In 2010, the company changed its name from Graphene Solutions, Inc. and operates as a subsidiary of Reliance Industries Limited.

Regentis Biomaterials

Series C in 2012
Regentis Biomaterials Ltd. is a tissue repair company specializing in the development and commercialization of biodegradable hydrogels aimed at regenerating damaged cartilage tissue. The company's primary product, GelrinC, is a hydrogel designed for the treatment of articular cartilage lesions and is currently undergoing clinical trials. GelrinC serves a range of orthopedic applications, including microfracture and autologous chondrocyte implantation procedures. The hydrogel platform, Gelrin, combines polyethylene glycol diacrylate and denatured fibrinogen, offering both the stability of synthetic materials and the bio-functionality of natural substances. Founded in 2004, Regentis Biomaterials is headquartered in Or-Akiva, Israel, with an additional office in Princeton, New Jersey. The company is committed to enhancing patient health and quality of life through innovative tissue repair solutions.

Verdezyne

Venture Round in 2011
Verdezyne is a private company focused on synthetic biology, utilizing its expertise and advanced computational algorithms to design and synthesize diverse gene libraries for engineering proteins, metabolic pathways, and microorganisms. By optimizing commercial fermentation processes, Verdezyne produces renewable chemical alternatives to petrochemicals. The company’s innovative platform combines synthetic biology with established manufacturing technologies to create a wide range of building blocks, offering sustainable and cost-effective solutions for everyday chemicals and additives. This approach aims to reduce reliance on oil and transform traditional chemical production methods.

CellMade

Funding Round in 2010
CellMade SAS is a biopharmaceutical company based in Chappes, France, with additional facilities in Marseille and Ruffieux. Founded in 2007, the company specializes in developing and supplying a range of cell biology products, including human-origin primary cells and various types of specialized cells such as blood cells, endothelial cells, and pancreatic cells. CellMade also offers laboratory services that encompass biobanking, cell-based assays, cytometry, and mass spectrometry. The company invests in its research and development initiatives through its CellInsight platform, which focuses on identifying targets and biomarkers associated with inflammatory pathologies. By providing customized cell isolation and co-culture models, CellMade aims to advance the field of cell biology and support various research applications.

Segetis

Series B in 2010
Segetis, Inc. is a green chemistry company specializing in the development, production, and commercialization of renewable polymers. Founded in 2006 and based in Golden Valley, Minnesota, the company utilizes a platform of binary monomers derived from renewable feedstocks, such as non-food agricultural and forestry materials. Segetis's innovative technology supports the production of a range of industrial bioproducts, including bio-plastics, surfactants, plasticizers, adhesives, and coalescent solvents, among others. The company's chemistries create opportunities for synergy across various industries, including those involved in starch and sugar crop processing, wood and cellulose processing, vegetable oil chemical processing, biodiesel manufacturing, and the production of linear alpha-olefins.

Novomer

Series B in 2009
Novomer is a materials company focused on developing high-performance, eco-friendly plastics, polymers, and chemicals. Established in 2004 and based in Waltham, Massachusetts, the company leverages proprietary catalytic technology to convert carbon dioxide and other renewable materials into cost-effective industrial products. This innovative approach combines traditional chemical feedstocks with carbon, enabling the sustainable synthesis of a range of chemicals and materials. Novomer’s technology not only offers competitive pricing but also contributes to environmental sustainability by addressing global warming and climate change challenges through the use of carbon in industrial applications.

Viocare

Venture Round in 2009
Viocare, Inc. is a private company focused on advancing nutrition and behavior change through innovative web and mobile solutions. It has developed a cloud-based wellness and nutrition tracking platform that provides assessment tools for researchers and clinicians. The platform analyzes patients' dietary behaviors to create personalized lifestyle plans and offers actionable nutritional counseling. This counseling can be delivered remotely via telehealth or in-person, allowing healthcare professionals to integrate effective and affordable nutritional guidance into their practice. By focusing on sustainable behavior change, Viocare aims to improve the living standards of patients through tailored nutrition plans.

Provexis

Post in 2008
Provexis plc is a UK-based company that specializes in the development, licensing, and marketing of functional foods, medical foods, and dietary supplements on a global scale. Founded in 1999 and headquartered in Reading, Provexis is known for its flagship product, Fruitflow, a tomato extract that helps reduce the risk of abnormal blood clotting associated with cardiovascular diseases, including heart attacks and strokes. Fruitflow is available in syrup and powder forms, which can be incorporated into various food, beverage, and dietary supplement products. Additionally, Provexis offers Fruitflow + Omega-3, a capsule supplement that promotes healthy blood flow and supports normal heart function. The company has a collaboration agreement with By-Health Co., Ltd. and distributes its products through retail outlets and online platforms.

Ganeden Biotech

Venture Round in 2007
Ganeden, Inc. is a manufacturer and supplier of probiotics and probiotic bacteria, focusing on the development of superior strains through a proprietary fermentation process. The company licenses its probiotic technology for various applications, including functional foods and beverages, dietary supplements, and topical products. Notable offerings include GanedenBacillus coagulans for food and companion animal use, Bonicel for personal care products aimed at anti-aging, and Staimune for immune health. Established in 1997 and headquartered in Mayfield Heights, Ohio, Ganeden has launched successful consumer lines such as Digestive Advantage and Sustenex, selling nearly 200 million doses across over 40,000 retail outlets. The company also maintains a strategic alliance with Sensus America. As of October 2017, Ganeden operates as a subsidiary of Kerry Group plc.

Food Quality Sensor International

Series B in 2007
Food Quality Sensor International, Inc. is a sensor technology company based in Lexington, Massachusetts, founded in 2004. It specializes in the development and commercialization of real-time and interactive devices for measuring food freshness. The company's primary products include SensorQ, which assesses the freshness of meat and poultry within their packaging, and SensorfreshQ, a handheld device that identifies spoilage in these products. Food Quality Sensor International serves a variety of markets, including food processing, grocery distribution, food service, regulatory bodies, defense, and consumer retail.

Harland Medical Systems

Private Equity Round in 2007
Harland Medical Systems, Inc. specializes in surface enhancement products for the healthcare industry, focusing on medical device coatings and related services. Founded in 2002 and headquartered in Eden Prairie, Minnesota, the company offers a range of solutions including antimicrobial coatings, coating materials for surface modification, and method development services for medical devices. Harland Medical Systems provides various coating systems for applying ultraviolet cured coatings, along with friction test equipment to assess the performance of lubricious coatings on devices such as catheters and guide wires. The company serves a diverse clientele across multiple clinical markets including neurology, urology, cardiology, wound care, and endoscopy, aiming to enhance patient outcomes and improve the economic value of healthcare products and procedures.

Micromuscle

Venture Round in 2006
Micromuscle AB, established in 2000, specializes in the development of innovative biomedical products utilizing its proprietary electroactive polymer technology, known as MICROMUSCLE technology. This technology enables electroactive polymers to expand and contract in response to an electric potential, making it particularly suitable for various vascular applications. The company's focus on electro-active polymers positions it at the forefront of biomedical advancements, aiming to enhance medical treatments and devices through its unique material properties.

IntegraGen

Venture Round in 2006
IntegraGen is a French biotechnology company located in the Genopole life science park in Evry, near Paris. The company focuses on the development of genetic biomarkers and offers a range of genomic and bioinformatic services. These services cater to the pharmaceutical industry, biotech firms, and various research institutions, encompassing clinical research, basic and human genetic research, bioinformatics, and bioanalysis. Additionally, IntegraGen provides solutions for agrigenomics and offers tools for microbiologic research, capitalizing on its unique intellectual property and research expertise.

Sciona

Series C in 2006
Sciona provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. The company's Mycellf Program, which includes a diet and lifestyle questionnaire, makes recommendations for how individuals can make choices that benefit their long-term health. It also offers genetic testing products, which address personal wellness, fitness, and nutritional issues. The company was founded in 2000 and is headquartered in Aurora, Colorado.

ORYXE Energy International

Venture Round in 2005
ORYXE Energy International was founded in 2001 to solve the world’s dual need for dependable fuel supplies and a cleaner environment. By focusing on a specific challenge—cleaner-burning fuels—they have developed innovative additive technologies that improve fuel performance and make a meaningful reduction in toxic emissions from renewable and fossil fuels. Their products are proven, safe, cost-effective and available worldwide.

Sciona

Series B in 2004
Sciona provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. The company's Mycellf Program, which includes a diet and lifestyle questionnaire, makes recommendations for how individuals can make choices that benefit their long-term health. It also offers genetic testing products, which address personal wellness, fitness, and nutritional issues. The company was founded in 2000 and is headquartered in Aurora, Colorado.

Morphotek

Series C in 2004
Morphotek, established in 2000, is a prominent life science company specializing in developing novel biological products to combat cancer, inflammation, and infectious diseases. The company's core technology, morphogenics, was co-invented by its current President and CEO, Dr. Nicholas Nicolaides, during his postgraduate research at Johns Hopkins Medical School. Morphotek focuses on discovering and developing monoclonal antibodies (mAbs) using this proprietary technology to treat various conditions such as ovarian and pancreatic cancers, rheumatoid arthritis, and asthma. The company conducts independent research and clinical development programs for its drug candidates.

Optiva

Series C in 2003
Optiva develops and manufactures nanomaterials for use in optical, electro-optical, and semiconductor applications.

Sciona

Series A in 2002
Sciona provides gene-based personalized health and nutrition analysis and recommendations based on individual diet, lifestyle, and genetic profile. The company's Mycellf Program, which includes a diet and lifestyle questionnaire, makes recommendations for how individuals can make choices that benefit their long-term health. It also offers genetic testing products, which address personal wellness, fitness, and nutritional issues. The company was founded in 2000 and is headquartered in Aurora, Colorado.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.